| Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease P Anglade, S Vyas, F Javoy-Agid, MT Herrero Ezquerro, PP Michel, ... Histology and histopathology, 1997 | 1395 | 1997 |
| Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease A Hartmann, S Hunot, PP Michel, MP Muriel, S Vyas, BA Faucheux, ... Proceedings of the National Academy of Sciences 97 (6), 2875-2880, 2000 | 895 | 2000 |
| Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease S Hunot, B Brugg, D Ricard, PP Michel, MP Muriel, M Ruberg, ... Proceedings of the National Academy of Sciences 94 (14), 7531-7536, 1997 | 884 | 1997 |
| Understanding dopaminergic cell death pathways in Parkinson disease PP Michel, EC Hirsch, S Hunot Neuron 90 (4), 675-691, 2016 | 631 | 2016 |
| Selective and nonselective stimulation of central cholinergic and dopaminergic development in vitro by nerve growth factor, basic fibroblast growth factor, epidermal growth … B Knusel, PP Michel, JS Schwaber, F Hefti Journal of Neuroscience 10 (2), 558-570, 1990 | 607 | 1990 |
| The role of glial reaction and inflammation in Parkinson's disease EC Hirsch, T Breidert, E Rousselet, S Hunot, A Hartmann, PP Michel Annals of the New York Academy of Sciences 991 (1), 214-228, 2003 | 566 | 2003 |
| Levodopa in the treatment of Parkinson's disease: current controversies CW Olanow, Y Agid, Y Mizuno, A Albanese, U Bonucelli, P Damier, ... Movement disorders 19 (9), 997-1005, 2004 | 510 | 2004 |
| Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats GU Höglinger, J Féger, A Prigent, PP Michel, K Parain, P Champy, ... Journal of neurochemistry 84 (3), 491-502, 2003 | 422 | 2003 |
| Toxicity of 6‐hydroxydopamine and dopamine for dopaminergic neurons in culture PP Michel, F Hefti Journal of neuroscience research 26 (4), 428-435, 1990 | 420 | 1990 |
| Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease GU Höglinger, G Carrard, PP Michel, F Medja, A Lombès, M Ruberg, ... Journal of neurochemistry 86 (5), 1297-1307, 2003 | 337 | 2003 |
| The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease GU Höglinger, JJ Breunig, C Depboylu, C Rouaux, PP Michel, ... Proceedings of the National Academy of Sciences 104 (9), 3585-3590, 2007 | 326 | 2007 |
| Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe P Champy, GU Höglinger, J Féger, C Gleye, R Hocquemiller, A Laurens, ... Journal of neurochemistry 88 (1), 63-69, 2004 | 283 | 2004 |
| Ceramide induces apoptosis in cultured mesencephalic neurons B Brugg, PP Michel, Y Agid, M Ruberg Journal of neurochemistry 66 (2), 733-739, 1996 | 247 | 1996 |
| The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy GU Höglinger, A Lannuzel, ME Khondiker, PP Michel, C Duyckaerts, ... Journal of neurochemistry 95 (4), 930-939, 2005 | 233 | 2005 |
| Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons M Escobar-Khondiker, M Höllerhage, MP Muriel, P Champy, A Bach, ... Journal of Neuroscience 27 (29), 7827-7837, 2007 | 230 | 2007 |
| Mitochondrial free radical signal in ceramide‐dependent apoptosis: a putative mechanism for neuronal death in Parkinson's disease V France‐Lanord, B Brugg, PP Michel, Y Agid, M Ruberg Journal of neurochemistry 69 (4), 1612-1621, 1997 | 227 | 1997 |
| The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism A Lannuzel, PP Michel, GU Höglinger, P Champy, A Jousset, F Medja, ... Neuroscience 121 (2), 287-296, 2003 | 198 | 2003 |
| Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? A Hartmann, PP Michel, JD Troadec, A Mouatt‐Prigent, BA Faucheux, ... Journal of neurochemistry 76 (6), 1785-1793, 2001 | 197 | 2001 |
| Are dopaminergic neurons selectively vulnerable to Parkinson's disease? Y Agid, M Ruberg, F Javoy-Agid, E Hirsch, R Raisman-Vozari, S Vyas, ... Advances in neurology 60, 148-164, 1993 | 196 | 1993 |
| Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease C Noelker, L Morel, T Lescot, A Osterloh, D Alvarez-Fischer, M Breloer, ... Scientific reports 3 (1), 1393, 2013 | 194 | 2013 |
Rita RaismanDirecteur de Recherche CNRS在 upmc.fr 的电子邮件经过验证
